The change of retinal sensitivity with intravitreal injection of aflibercept for wet type of age-related macular degeneration. - The change of retinal sensitivity with IVA for AMD

Department of Ophthalmology and Visual Science Chiba University Graduate School of Medicine0 sites40 target enrollmentJanuary 1, 2015

Overview

Phase: 未知
Intervention: Not specified
Conditions: wet type age-related macular degeneration
Sponsor: Department of Ophthalmology and Visual Science Chiba University Graduate School of Medicine
Enrollment: 40
Status: Completed
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

January 1, 2015

End Date

March 9, 2019

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

Department of Ophthalmology and Visual Science Chiba University Graduate School of Medicine

•1\.Patients who need to undergo intravitreal injection of aflibercept for their both eyes. 2\.The lesion is more than 12 disc diameter area with fluorecein angiography 3\.Subretinal hemorrhage with 50 percent or more of the lesion area 4\.Subretinal scar or fibrosis with 50 percent or more of the lesion area 5\.retinal pigment epithelium tear 6\.patients who had past stage 3 or 4 macular hole 7\.patients who received the therapy with triamcinolone acetonide within 6 months 8\.patients who received the therapy with Dexamethasone within 30 days 9\.patients who received intra occular surgery within 6 months 10\.patients who received pars plana vitrectomy or submacular surgery 11\.patinets with intra or external occular infection or inflamation 12\.patients with uveitis in any eye 13\.fluorescein or indocianine green alergy 14\.pregnancy or possibility of pregnancy or woman who are lactating 15\.patient who are judged unsuitable for the investigation by the doctor